SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-22-093799
Filing Date
2022-04-01
Accepted
2022-04-01 16:52:32
Documents
1
Effectiveness Date
2022-04-01

Document Format Files

Seq Description Document Type Size
1 S-8 POS d343128ds8pos.htm S-8 POS 26290
  Complete submission text file 0001193125-22-093799.txt   27658
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-257446 | Film No.: 22799065
SIC: 2836 Biological Products, (No Diagnostic Substances)